Motion Sickness Treatment Market Intelligence Report: Novel Medications, Growth Scope, Future Growth | WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Relifeband Technologies, and CVS Health, Prestige Brands, Inc., Baxter International, Inc

DataM Intelligence has published a new research report on "Motion Sickness Treatment Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

According to the WHO, the global geriatric population was 1 billion in 2020 and is projected to grow to 1.4 billion by 2030 and 2.1 billion by 2050.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/motion-sickness-treatment-market?kb

Latest M&A Activity

The motion sickness treatment market sees moderate M&A focused on acquiring innovative device and drug candidates. Larger pharmaceutical firms and consumer healthcare companies are investing in neuromodulation wearables and novel drug candidates to diversify beyond traditional antihistamines and anticholinergics.​

Startups integrating sensory alignment with virtual reality or AI-assisted therapies, such as VMocion, attracted venture capital funding, providing opportunities for acquisition by major industry players.​

Companies like Prestige Consumer Healthcare, Perrigo, and Reliefband Technologies maintain competitive positions through organic growth and acquisitions of complementary health device portfolios.

Key Players:

Prestige Brands, Inc., Baxter International, Inc., GlaxoSmithKline plc, Myungmoon Pharm Co. Ltd., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Inc., Johnson & Johnson Services Inc., Pfizer, Relifeband Technologies, and CVS Health

Latest FDA Approvals (2024-2025)

Vanda Pharmaceuticals' tradipitant, a NK1 receptor antagonist, is under FDA review for motion sickness with a PDUFA target date of December 30, 2025.​

FDA issued a safety warning in June 2025 about heat-related risks associated with the Transderm Scop® scopolamine patch, prompting label revisions but reaffirming its use for nausea and vomiting prevention in motion sickness.​

No new novel drug approvals for motion sickness have been announced yet in 2024-2025; however, existing first-generation antihistamines (diphenhydramine, cyclizine, meclizine) remain widely used therapies with recognized efficacy and side-effect profiles.

Growth Forecast Projected:

The Global Motion Sickness Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Motion Sickness Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=motion-sickness-treatment-market?kb

Key Segments:

By Type: (Anticholinergic, Antihistamines, Others)

By Route of Administration: (Transdermal, Oral)

By Distribution Channel: (Retail Pharmacies, Online Stores)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Motion Sickness Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Motion Sickness Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/motion-sickness-treatment-market?kb

FAQ's

Q: How fast is the Motion Sickness Treatment Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 3.0% from 2025 to 2032

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/motion-sickness-treatment-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.